Firifam Tablet

About Firifam 150 mg Tablet

Firifam 150 mg Tablet contains rifampicin, an antibiotic used mainly in tuberculosis treatment and to clear meningococcal bacteria from carriers. It works by blocking bacterial RNA production. Doctors prescribe it as part of a wider treatment plan.

There are 18 brands of Rifampicin listed in Bangladesh. By unit price, Firifam is among the cheapest of them.

What is Firifam 150 mg Tablet?

Firifam 150 mg Tablet is an anti-tubercular antibiotic with rifampicin as its active ingredient. It is used in the treatment of tuberculosis and in people who carry meningococcal bacteria without being ill. Rifampicin works by interfering with the bacteria's ability to make RNA, which stops their growth. Firifam is available as a 150 mg tablet. It is usually taken as part of a combination regimen for tuberculosis, and the doctor decides the exact dose and duration. Because rifampicin can affect the liver and interacts with many other medicines, it should only be used under medical supervision, with regular check-ups as advised.

Uses of Firifam

Firifam 150 mg Tablet is used to treat tuberculosis, a bacterial infection that usually affects the lungs, and to clear meningococcal bacteria from the nose and throat in people who carry them without symptoms. In tuberculosis, it is given together with other anti-tubercular medicines. The doctor will confirm the infection and decide whether Firifam is suitable. It is not a treatment for viral infections such as colds or flu.

How to use Firifam

Firifam 150 mg Tablet is taken by mouth. The doctor decides the dose, how often to take it, and how long the course should last; never change these on your own. It is often taken once daily, either about an hour before or two hours after a meal, with a full glass of water, but follow your doctor's instructions. Swallow the tablet whole. If you miss a dose, ask your doctor or pharmacist what to do. Do not stop taking it early, even if you feel better.

Side effects of Firifam

Firifam can cause facial flushing and itching, sometimes with a rash. Flu-like symptoms such as fever, chills, headache, dizziness, bone pain, shortness of breath, and tiredness may occur. Stomach upset, including nausea, vomiting, loss of appetite, diarrhoea, and indigestion, is possible. It commonly turns urine, faeces, sweat, saliva, sputum, and tears an orange-red colour; this is expected but tell your doctor if it worries you. Other effects include changes in blood counts, kidney problems, menstrual changes, swelling, and muscle weakness. Seek medical advice if side effects are severe or persistent.

Safety and precautions

Tell your doctor before starting Firifam if you have liver disease, kidney problems, or have had an allergic reaction to rifampicin or similar antibiotics. Rifampicin can affect the liver, so your doctor may arrange liver function tests before and during treatment. It interacts with many medicines, including some antivirals, blood thinners, epilepsy drugs, and antacids, so give your doctor a full list of everything you take. In the last weeks of pregnancy, rifampicin can cause bleeding in the mother and newborn, and vitamin K treatment may be needed. If you are pregnant or breastfeeding, speak to your doctor before using it.

Frequently asked questions

How should Firifam 150 mg Tablet be taken?

Firifam is taken by mouth, usually with a full glass of water. The doctor decides the dose, how often to take it, and how long the course lasts, based on your condition. Follow their instructions exactly and do not stop early without checking with them.

What is Firifam 150 mg Tablet used for and what kind of medicine is it?

Firifam contains rifampicin, an antibiotic that belongs to the anti-tubercular group. It is used to treat tuberculosis, usually alongside other medicines, and to clear meningococcal bacteria from people who carry them without being ill. It does not treat viral infections.

Which medicines may interact with Firifam?

Rifampicin can interact with many medicines, including quinidine, phenytoin, theophylline, atovaquone, ketoconazole, enalapril, antacids, halothane, isoniazid, and certain HIV antivirals. Some combinations are not recommended. Always tell your doctor and pharmacist about every medicine you take, including over-the-counter products.

What should I tell my doctor before starting Firifam?

Tell your doctor about any liver or kidney problems, allergies to rifampicin or related antibiotics, pregnancy or breastfeeding, and all other medicines you use. Your doctor may monitor your liver function during treatment. Do not start or stop any medicine without their advice.

Tablet
Generic name
Rifampicin
Strength
150 mg
Dosage form
Tablet
Manufactured by
Synovia Pharma PLC.
Price in Bangladesh

৳ 0.98 ৳ 1 2% off unit price

Price updated: 16 Nov 2026

Also available as

450 mg (Tablet)

Indications

In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the ... Read moreIn the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampinand they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regimen should be modified.

Pharmacology

Rifampicin suppresses initiation of chain formation for RNA synthesis in susceptible bacteria by binding to the β subunit of DNA-dependent RNA polymerase, thus blocking RNA transcription.

Dosage & Administration

Rifampin can be administered by the oral route or by IV infusion. IV doses are the same as those for oral.

Tuberculosis:
  • Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
  • Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
It is recommended that oral rifampin be administered once daily, either 1 hour before or 2 hours after a meal with a full glass of water.

Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.

Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.

Interaction

May accelerate the metabolism and reduce the effect of drugs that are metabolised by CYP450 enzymes (e.g. quinidine, phenytoin, theophylline). Decreased concentrations of atovaquone and increased concentrations of rifampicin when taken concomitantly. Concurrent use of ketoconazole and rifampicin may result in decreased serum concentrations of both drugs. May decrease serum concentrations of enalaprilat. Reduced absorption by antacids. Increased risk of hepatotoxicity with halothane or isoniazid.

Contraindications

Rifampicin is contraindicated in patients with a history of hypersensitivity to rifampin or any of the components, or to any of the rifamycins. Rifampin is contraindicated in patients who are also receiving ritonavir-boosted saquinavir due to an increased risk of severe hepatocellular toxicity.

Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.

Side Effects

Facial flushing and itching, with or without a rash, flu-like syndrome characterised by episodes of fever, chills, headache, dizziness, bone pain, shortness of breath, and malaise; GI adverse effects (e.g. nausea, vomiting, anorexia, diarrhoea, epigastric distress), pseudomembranous colitis, eosinophilia, leucopenia, haemolytic anaemia; alterations in kidney function and renal failure, menstrual disturbances, oedema, myopathy, muscular weakness; orange-red discolouration of the urine, faeces, sweat, saliva, sputum, tears, and other body fluids; thrombophlebitis, local irritation and inflammation after prolonged IV infusion. Rarely, eye irritation and visual disturbances, anaphylaxis or shock.

Pregnancy & Lactation

Pregnancy: When administered during the last few weeks of pregnancy, rifampin can cause post natal hemorrhages in the mother and infant for which treatment with vitamin K may be indicated.

Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

Rifampicin has been shown to produce liver dysfunction. Fatalities associated with jaundice have occurred in patients with liver disease and in patients taking rifampin with other hepatotoxic agents. Patients with impaired liver function should be given rifampin only in cases of necessity and then with caution and under strict medical supervision. In these patients, careful monitoring of liver function, especially SGPT/ALT and SGOT/AST should be carried out prior to therapy and then every 2 to 4 weeks during therapy. If signs of hepatocellular damage occur, rifampin should be withdrawn.

In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.

Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.

Overdose Effects

Nausea, vomiting, abdominal pain, pruritus, headache, and increasing lethargy will probably occur within a short time after ingestion; unconsciousness may occur when there is severe hepatic disease. Transient increases in liver enzymes and/or bilirubin may occur. Brownish-red or orange discoloration of the skin, urine, sweat, saliva, tears, and feces will occur, and its intensity is proportional to the amount ingested.

Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.

Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.

Storage Conditions

Store between 15-30° C. Avoid excessive heat and protect from light.

Alternative brands of Rifampicin

Other brands with the same generic name, cheapest first.

Firifam Tablet

450 mg

Rifampicin

Synovia Pharma PLC.

৳ 0.98 ৳ 1 2% off per unit

Rifcin Capsule

150 mg

Rifampicin

Pharmadesh Laboratories Ltd.

৳ 10.81 ৳ 11.03 2% off per unit

Rifatan Syrup

100 mg/5 ml

Rifampicin

G. A. Company Ltd.

৳ 28.8 ৳ 29.39 2% off per unit

Rifcin Syrup

100 mg/5 ml

Rifampicin

Pharmadesh Laboratories Ltd.

৳ 78.4 ৳ 80.00 2% off per unit

See all 18 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.